i
n
f
l
a
r
x
Loading
About Inflarx
Leadership Team
Board of Directors
Company History
R & D
Pipeline
Vilobelimab
INF904
IFX002
Complement Platform
Clinical Development
Pyoderma Gangraenosum
COVID-19
Clinical Trials
Publications & Posters
Investors
Press Releases
Events
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Shareholder Meetings
Email alerts
Careers
The InflaRx Commitment
About Inflarx
Leadership Team
Board of Directors
Company History
R & D
Pipeline
Vilobelimab
INF904
IFX002
Complement Platform
Clinical Development
Pyoderma Gangraenosum
COVID-19
Clinical Trials
Publications & Posters
Investors
Press Releases
Events
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Shareholder Meetings
Email alerts
Careers
The InflaRx Commitment
Financial Information
Home
Investors
Financial Information
Financial-Information InflaRx SEC filings and financial reports
The following list represents all InflaRx SEC filings and financial reports.
Select year:
2025
2024
2023
2022
2021
2020
2019
2018
2017
Filter filing type:
annual reports
registration statements (including forms F-1, F-3, prospectuses and S-8)
current reports (6-k), including quarterly reports
statements of beneficial ownership
other
all
Date
Filing Type
Filing Description
Download / View
2025-02-18
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-02-18
424B5
Prospectus [Rule 424(b)(5)]
2025-02-13
424B5
Prospectus [Rule 424(b)(5)]
2025-01-15
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
See also in Investors:
Press Releases
Events
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Shareholder Meetings
Email alerts